Developing Targeted Therapeutics for Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration (AMD) is the leading cause of visual loss in adults age 50 and older in the western world. Ophthotech is developing products that target key molecular events driving both dry and wet AMD.